BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18991689)

  • 1. Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome.
    Di Renzo L; Bertoli A; Bigioni M; Del Gobbo V; Premrov MG; Calabrese V; Di Daniele N; De Lorenzo A
    Curr Pharm Des; 2008; 14(26):2699-706. PubMed ID: 18991689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in normal-weight obese syndrome.
    Di Renzo L; Galvano F; Orlandi C; Bianchi A; Di Giacomo C; La Fauci L; Acquaviva R; De Lorenzo A
    Obesity (Silver Spring); 2010 Nov; 18(11):2125-30. PubMed ID: 20339360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of relationship between 174G_C promoter polymorphism of the IL-6 gene and indices of metabolic syndrome in non-obese healthy subjects.
    Tworowska-Bardzińska U; Kubicka E; Slezak R; Mielcarek M; Bednarek-Tupikowska G; Bolanowski M; Milewicz A
    Endokrynol Pol; 2009; 60(3):172-9. PubMed ID: 19569017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of interleukin 6 -174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight.
    Goyenechea E; Parra D; Martínez JA
    Metabolism; 2007 Dec; 56(12):1643-8. PubMed ID: 17998015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition changes after laparoscopic adjustable gastric banding: what is the role of -174G>C interleukin-6 promoter gene polymorphism in the therapeutic strategy?
    Di Renzo L; Carbonelli MG; Bianchi A; Iacopino L; Fiorito R; Di Daniele N; De Lorenzo A
    Int J Obes (Lond); 2012 Mar; 36(3):369-78. PubMed ID: 21730965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polycystic ovary syndrome per se is not associated with increased chronic inflammation.
    Möhlig M; Spranger J; Osterhoff M; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Eur J Endocrinol; 2004 Apr; 150(4):525-32. PubMed ID: 15080783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal-weight obese syndrome: early inflammation?
    De Lorenzo A; Del Gobbo V; Premrov MG; Bigioni M; Galvano F; Di Renzo L
    Am J Clin Nutr; 2007 Jan; 85(1):40-5. PubMed ID: 17209175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance.
    Cardellini M; Perego L; D'Adamo M; Marini MA; Procopio C; Hribal ML; Andreozzi F; Frontoni S; Giacomelli M; Paganelli M; Pontiroli AE; Lauro R; Folli F; Sesti G
    Diabetes Care; 2005 Aug; 28(8):2007-12. PubMed ID: 16043746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of the rs6923761 gene variant in glucagon-like peptide 1 receptor with weight, cardiovascular risk factor, and serum adipokine levels in obese female subjects.
    de Luis DA; Aller R; de la Fuente B; Primo D; Conde R; Izaola O; Sagrado MG
    J Clin Lab Anal; 2015 Mar; 29(2):100-5. PubMed ID: 24687535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between -308 G/A TNF-α polymorphism and appendicular skeletal muscle mass index as a marker of sarcopenia in normal weight obese syndrome.
    Di Renzo L; Sarlo F; Petramala L; Iacopino L; Monteleone G; Colica C; De Lorenzo A
    Dis Markers; 2013; 35(6):615-23. PubMed ID: 24285913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study.
    Klipstein-Grobusch K; Möhlig M; Spranger J; Hoffmann K; Rodrigues FU; Sharma AM; Klaus S; Pfeiffer AF; Boeing H
    Obesity (Silver Spring); 2006 Jan; 14(1):14-8. PubMed ID: 16493118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 gene promoter -174G/C polymorphism and insulin resistance: a pilot study.
    Tretjakovs P; Latkovskis G; Licis N; Juhnevica D; Jurka A; Bormane I; Aivars JI; Stifts A; Pirags V
    Clin Chem Lab Med; 2007; 45(9):1145-8. PubMed ID: 17848119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.
    Mackawy AM
    Gene; 2013 Nov; 530(1):158-63. PubMed ID: 23958652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of -174 G>C interleukin-6 gene polymorphism with interleukin-6 and c-reactive protein levels and obesity: A case-control study among people/residents of Western Indonesia.
    Pramudji H; Demes CM; Dewi K; Tasmini T; Ahmad HS
    Med J Malaysia; 2019 Oct; 74(5):400-404. PubMed ID: 31649216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. -174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers.
    Di Renzo L; Bianchi A; Saraceno R; Calabrese V; Cornelius C; Iacopino L; Chimenti S; De Lorenzo A
    Pharmacogenet Genomics; 2012 Feb; 22(2):134-42. PubMed ID: 22158445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance.
    Underwood PC; Chamarthi B; Williams JS; Sun B; Vaidya A; Raby BA; Lasky-Su J; Hopkins PN; Adler GK; Williams GH
    Metabolism; 2012 May; 61(5):667-71. PubMed ID: 22075267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TNF-alpha gene NcoI polymorphism at position -308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity.
    Wybrańska I; Malczewska-Malec M; Niedbał S; Naskalski JW; Dembińska-Kieć A
    Clin Chem Lab Med; 2003 Apr; 41(4):501-10. PubMed ID: 12747594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity.
    Dalziel B; Gosby AK; Richman RM; Bryson JM; Caterson ID
    Obes Res; 2002 May; 10(5):401-7. PubMed ID: 12006640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.